WELLS FARGO & COMPANY/MN - NABRIVA THERAPEUTICS PLC ownership

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$60
-14.3%
400.0%0.00%
Q1 2023$70
+677.8%
40
+700.0%
0.00%
Q4 2022$95
-54.5%
0.00%
Q3 2022$0110.00%
Other shareholders

There were no reported owners of NABRIVA THERAPEUTICS PLC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of NABRIVA THERAPEUTICS PLC shareholders